Geode Capital Management, LLC Bio Xcel Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.26 Trillion
Q4 2024

A detailed history of Geode Capital Management, LLC transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 311,965 shares of BTAI stock, worth $720,639. This represents 0.0% of its overall portfolio holdings.

Number of Shares

311,965

Previous 298,043 4.67%

Holding current value

$720,639

Previous $181,000 36.46%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$0.32 - $0.73 $4,455 - $10,163	13,922 Added 4.67%	311,965 $115,000
Q3 2024 Nov 12, 2024	BUY	$0.53 - $1.34 $16,601 - $41,974	31,324 Added 11.74%	298,043 $181,000
Q2 2024 Aug 09, 2024	SELL	$1.14 - $2.97 $217,969 - $567,866	-191,201 Reduced 41.75%	266,719 $341,000
Q1 2024 May 13, 2024	BUY	$1.95 - $4.04 $15,001 - $31,079	7,693 Added 1.71%	457,920 $1.29 Million
Q4 2023 Feb 13, 2024	BUY	$2.32 - $5.51 $62,888 - $149,359	27,107 Added 6.41%	450,227 $1.33 Million
Q3 2023 Nov 13, 2023	BUY	$2.49 - $11.85 $45,990 - $218,869	18,470 Added 4.56%	423,120 $1.07 Million
Q2 2023 Aug 11, 2023	BUY	$6.39 - $28.58 $137,519 - $615,070	21,521 Added 5.62%	404,650 $2.69 Million
Q1 2023 May 15, 2023	BUY	$17.7 - $33.24 $143,901 - $270,241	8,130 Added 2.17%	383,129 $7.15 Million
Q4 2022 Feb 13, 2023	BUY	$10.25 - $22.43 $199,577 - $436,734	19,471 Added 5.48%	374,999 $8.05 Million
Q3 2022 Nov 14, 2022	BUY	$11.19 - $17.89 $132,377 - $211,638	11,830 Added 3.44%	355,528 $4.2 Million
Q2 2022 Aug 12, 2022	BUY	$9.03 - $21.55 $289,962 - $691,992	32,111 Added 10.31%	343,698 $4.54 Million
Q1 2022 May 13, 2022	BUY	$15.0 - $22.83 $154,350 - $234,920	10,290 Added 3.42%	311,587 $6.52 Million
Q4 2021 Feb 11, 2022	BUY	$20.12 - $35.09 $85,670 - $149,413	4,258 Added 1.43%	301,297 $6.13 Million
Q3 2021 Nov 12, 2021	BUY	$23.84 - $32.03 $482,044 - $647,646	20,220 Added 7.3%	297,039 $9.02 Million
Q2 2021 Aug 13, 2021	BUY	$29.06 - $38.83 $702,641 - $938,870	24,179 Added 9.57%	276,819 $8.04 Million
Q1 2021 May 12, 2021	BUY	$39.04 - $64.6 $1.11 Million - $1.83 Million	28,403 Added 12.67%	252,640 $10.9 Million
Q4 2020 Feb 12, 2021	BUY	$42.46 - $56.58 $767,804 - $1.02 Million	18,083 Added 8.77%	224,237 $10.4 Million
Q3 2020 Nov 13, 2020	BUY	$37.44 - $64.63 $1.68 Million - $2.89 Million	44,770 Added 27.74%	206,154 $8.94 Million
Q2 2020 Aug 13, 2020	BUY	$17.62 - $58.71 $454,684 - $1.52 Million	25,805 Added 19.03%	161,384 $8.55 Million
Q1 2020 May 14, 2020	BUY	$12.26 - $41.14 $691,157 - $2.32 Million	56,375 Added 71.18%	135,579 $3.03 Million
Q4 2019 Feb 13, 2020	BUY	$4.05 - $14.61 $70,044 - $252,679	17,295 Added 27.94%	79,204 $1.16 Million
Q3 2019 Nov 12, 2019	BUY	$7.04 - $11.77 $10,320 - $17,254	1,466 Added 2.43%	61,909 $435,000
Q2 2019 Aug 14, 2019	BUY	$8.99 - $11.79 $315,557 - $413,840	35,101 Added 138.51%	60,443 $662,000
Q1 2019 May 14, 2019	BUY	$3.49 - $10.47 $88,443 - $265,330	25,342 New	25,342 $250,000

Others Institutions Holding BTAI

# of Institutions

Shares Held

8.69M

Call Options Held

22.2K

Put Options Held

27.7K

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $64.7M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Bio Xcel Therapeutics, Inc. Transaction History